Sacral and Implantable Tibial Neuromodulation for the Management of Overactive Bladder: A Systematic Review and Meta-analysis
Open Access
- 30 October 2024
- journal article
- review article
- Published by Springer Nature in Advances in Therapy
- Vol. 42 (1) , 10-35
Abstract
Introduction Implantable tibial neuromodulation (iTNM) systems have recently become commercially available in the US, and offer a new method of neurostimulation for the treatment of overactive bladder (OAB). In the absence of head-to-head studies, the aim of this meta-analysis was to indirectly compare the efficacy and safety of sacral neuromodulation (SNM) and implantable tibial neuromodulation (iTNM) for the treatment of OAB. Methods A comprehensive search was performed using terms for OAB and neuromodulation. Primary efficacy measures included a ≥ 50% reduction in urgency urinary incontinence (UUI) episodes, urinary frequency, and/or OAB symptoms. Primary safety measures included the rate of device-related adverse events (AEs). Results A total of 20 studies met selection criteria, encompassing 1416 patients treated with SNM and 350 patients treated with iTNM. No comparative or placebo-controlled studies for SNM and iTNM were identified, and therefore the analysis was completed using single-arm results. Weighted averages showed that the UUI responder rate was similar for both SNM and iTNM (71.8% and 71.3%, respectively). Similarly, weighted averages of OAB responder rates were 73.9% for SNM and 79.4% for iTNM. Similar rates of device-related AEs were also observed. Conclusions This meta-analysis found similar efficacy and safety of SNM and iTNM for the treatment of OAB and UUI, including UUI and OAB symptom response rates, reduction in UUI episodes, significant improvements in quality-of-life (QoL), and low rates of procedure and device-related adverse events. Notably, this comparable efficacy was seen without the use of a trial phase of neuromodulation in the iTNM studies versus SNM studies.Keywords
Funding Information
- BlueWind Medical
This publication has 84 references indexed in Scilit:
- Evaluation of clinical performance and safety for the rechargeable InterStim Micro device in overactive bladder subjects: 6‐month results from the global postmarket ELITE studyNeurourology and Urodynamics, 2023
- Efficacy of percutaneous and transcutaneous posterior tibial nerve stimulation on idiopathic overactive bladder and interstitial cystitis/painful bladder syndrome: A systematic review and meta‐analysisNeurourology and Urodynamics, 2022
- Sacral neuromodulation in patients with refractory overactive bladder symptoms after failed Botulinum toxin therapy: Results in a large cohort of patientsNeurourology and Urodynamics, 2021
- Two‐year outcomes of the ARTISAN‐SNM study for the treatment of urinary urgency incontinence using the Axonics rechargeable sacral neuromodulation systemNeurourology and Urodynamics, 2021
- Increased risk of incident dementia following use of anticholinergic agents: A systematic literature review and meta‐analysisNeurourology and Urodynamics, 2020
- Two‐year safety and efficacy outcomes for the treatment of overactive bladder using a long‐lived rechargeable sacral neuromodulation systemNeurourology and Urodynamics, 2020
- A novel leadless, miniature implantable Tibial Nerve Neuromodulation System for the management of overactive bladder complaintsNeurourology and Urodynamics, 2017
- Intermittent sacral neuromodulation for idiopathic urgency urinary incontinence in womenNeurourology and Urodynamics, 2015
- Cumulative Use of Strong Anticholinergics and Incident DementiaJAMA Internal Medicine, 2015
- Is on-demand sacral neuromodulation in patients with OAB syndrome a feasible therapy regime?Neurourology and Urodynamics, 2011